SCHEMBL6792836

SCHEMBL6792836

CC(CN(C=O)c1ccccc1)c1cc([N+](=O)[O-])ccn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
CRHBP P24387 2/20 0.38
CRHR2 Q13324 2/20 0.38
ATM Q13315 2/20 0.38
TLR9 Q9NR96 1/20 0.38
TRPM8 Q7Z2W7 1/20 0.37
LMNA P02545 3/20 0.37
RAB9A P51151 2/20 0.37
S1PR4 O95977 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
HTR7 P34969 1/20 0.35
FGFR1 P11362 1/20 0.35
ABCG2 Q9UNQ0 1/20 0.35
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6792689 0.81 OPRD1 (0.36) ALDH1A1L3MBTL1RAB9ANPC1
SCHEMBL6793045 0.77 CCNC (0.41) ALDH1A1MEN1KMT2AL3MBTL1CRHBP
SCHEMBL3716664 0.70 TSHR (0.42) ALDH1A1MEN1KMT2ALMNASMN1; SMN2
SCHEMBL8128151 0.69 ALDH1A1 (0.39) ALDH1A1MEN1KMT2ALMNASMN1; SMN2
Dinitrophenylene SCHEMBL27891496 0.67 TRPM8 (0.51) ALDH1A1MEN1KMT2AL3MBTL1CRHBP
SCHEMBL30000712 0.66 KMT2A (0.39) ALDH1A1MEN1KMT2AL3MBTL1LMNA
SCHEMBL30001467 0.66 KMT2A (0.39) ALDH1A1MEN1KMT2AL3MBTL1LMNA
SCHEMBL30001844 0.66 KMT2A (0.39) ALDH1A1MEN1KMT2AL3MBTL1LMNA
SCHEMBL30001445 0.66 KMT2A (0.39) ALDH1A1MEN1KMT2AL3MBTL1LMNA
SCHEMBL1852040 0.66 PDE4D (0.40) ALDH1A1MEN1KMT2ALMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040058903-A1 Benzamide compounds as apo b secretion inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058903-A1 Benzamide compounds as apo b secretion inhibitors APOB, APOL1, SCARB1 ALDH1A1 1427/4885MEN1 2426/4885KMT2A 2457/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.